Zentalis Pharmaceuticals
ZNTL
#9381
Rank
NZ$0.24 B
Marketcap
NZ$2.49
Share price
0.00%
Change (1 day)
4.18%
Change (1 year)

Earnings for Zentalis Pharmaceuticals (ZNTL)

Earnings in 2026 (TTM): -NZ$0.25 Billion

According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.25 Billion, an increase over its 2024 earnings that were of -NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zentalis Pharmaceuticals from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.25 Billion-3.27%
2025 -NZ$0.25 Billion-17.55%
2024 -NZ$0.31 Billion-40.16%
2023 -NZ$0.51 Billion25.12%
2022 -NZ$0.41 Billion34.48%
2021 -NZ$0.31 Billion39.33%
2020 -NZ$0.22 Billion154.74%
2019 -NZ$84.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion 14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million-86.92%๐Ÿ‡บ๐Ÿ‡ธ USA